المؤلفون: Paller, Amy S, Flohr, Carsten, Eichenfield, Lawrence F, Irvine, Alan D, Weisman, Jamie, Soung, Jennifer, Pinto Correia, Ana, Natalie, Chitra R, Rodriguez Capriles, Claudia, Pierce, Evangeline, Reifeis, Sarah, Gontijo Lima, Renata, Armengol Tubau, Clara, Laquer, Vivian, Weidinger, Stephan

المصدر: Dermatology and therapy. 13(7)

مصطلحات موضوعية: Adolescents, Efficacy, IL-13, Lebrikizumab, Moderate-to-severe atopic dermatitis, Safety, Depression, Mental Health, Clinical Research, Pediatric, Patient Safety, Clinical Trials and Supportive Activities, Brain Disorders, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Good Health and Well Being, Clinical Sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/216788xg
https://escholarship.org/content/qt216788xg/qt216788xg.pdf

المؤلفون: Paolo Amerio, Silvia Mariel Ferrucci, Marco Galluzzo, Maddalena Napolitano, Alessandra Narcisi, Anna Levi, Sara Di Fino, Chiara Palladino, Cataldo Patruno, Mariateresa Rossi

المصدر: Dermatology and Therapy, Vol 14, Iss 6, Pp 1443-1455 (2024)

مصطلحات موضوعية: Moderate-to-severe atopic dermatitis, Multidisciplinary approach, Holistic care, Dermatology, RL1-803

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172

URL الوصول: https://doaj.org/article/dca1283cbe5b447288e6cb7dd29a8cc6

المؤلفون: Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, Melissa Watkins

المصدر: Dermatology and Therapy, Vol 13, Iss 9, Pp 1893-1907 (2023)

مصطلحات موضوعية: Abrocitinib, Clinical practice, Flexible dosing, JAK1-selective inhibitor, Moderate-to-severe atopic dermatitis, Oral systemic therapy, Dermatology, RL1-803

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172

URL الوصول: https://doaj.org/article/910ab250dacb46cba12498d99a103afa

المؤلفون: Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R. Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger

المصدر: Dermatology and Therapy, Vol 13, Iss 7, Pp 1517-1534 (2023)

مصطلحات موضوعية: Adolescents, Efficacy, IL-13, Lebrikizumab, Moderate-to-severe atopic dermatitis, Safety, Dermatology, RL1-803

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172

URL الوصول: https://doaj.org/article/f1994888427840c4b87a98813eff0651

المؤلفون: Giuseppe Argenziano, Santo Raffaele Mercuri, Paola Savoia, Paolo Amerio, Anna Belloni Fortina, Maria Rita Bongiorno, Maria Beatrice De Felici Del Giudice, Aurora Parodi, Nicola Pimpinelli, Luca Stingeni, Michela Ortoncelli, Giuseppe Stinco, Giuliana Gualberti, Anna Levi, Valeria Scuderi, Luca Bianchi, Giovanna Malara

المصدر: Dermatology Practical & Conceptual, Vol 14, Iss 1 (2024)

مصطلحات موضوعية: real-life, moderate-to-severe atopic dermatitis, burden, patient-reported outcomes, QoL, Dermatology, RL1-803

وصف الملف: electronic resource

Relation: https://dpcj.org/index.php/dpc/article/view/3865; https://doaj.org/toc/2160-9381

URL الوصول: https://doaj.org/article/fdca0a0f92674c869ba17a11d5cee6e8

المؤلفون: Luca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara‐Pinton, Maddalena Napolitano, Ketty Peris, Donatella Schena

المساهمون: Stingeni, Luca, Chiricozzi, Andrea, Calzavara‐pinton, Piergiacomo, Napolitano, Maddalena, Peris, Ketty, Schena, Donatella

مصطلحات موضوعية: Atopic dermatitis is a chronic inflammatory disease characterized by acquired and innate immune dysregulation, impairment of the epithelial barrier function, and microbial dysbiosis. Disease registries play an important role in collecting and storing standardized information finalized to scientific, clinical, or policy purposes in public health and medicine. AtopyReg® is the Italian registry for moderate-to-severe atopic dermatitis in adults promoted by the Italian Society of Dermatology and Venereology (SIDeMaST) aimed to obtain prospective and longitudinal real-world, epidemiologic, and therapeutic data. We analyzed real-world data gathered from AtopyReg ®concerning baseline patients’ demographics and clinical and drug history, confirming the high burden of atopic dermatitis with a significant impact on patients’ quality of life

Relation: firstpage:149; lastpage:160; numberofpages:12; journal:AMERICAN JOURNAL OF CLINICAL DERMATOLOGY; https://hdl.handle.net/11562/1117568

الاتاحة: https://hdl.handle.net/11562/1117568
https://doi.org/10.1007/s40257-023-00819-y

المؤلفون: Pezzolo, Elena, Schena, Donatella, Gambardella, Alessio, Rossi, Mariateresa, Barei, Francesca, Calzavara Pinton, Piergiacomo, Girolomoni, Giampiero, Naldi, Luigi, Ferrucci, Silvia Mariel

المساهمون: Pezzolo, Elena, Schena, Donatella, Gambardella, Alessio, Rossi, Mariateresa, Barei, Francesca, Calzavara Pinton, Piergiacomo, Girolomoni, Giampiero, Naldi, Luigi, Ferrucci, Silvia Mariel

مصطلحات موضوعية: treatment for moderate-to-severe atopic dermatitis in adults

Relation: info:eu-repo/semantics/altIdentifier/pmid/37483150; info:eu-repo/semantics/altIdentifier/wos/WOS:001041020100001; volume:38; issue:1; firstpage:11; lastpage:13; numberofpages:3; journal:JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY; https://hdl.handle.net/11562/1116594

الاتاحة: https://hdl.handle.net/11562/1116594
https://doi.org/10.1111/jdv.19382

المؤلفون: Qin Gao, Yanxia Zhao, Junling Zhang

المصدر: Heliyon, Vol 9, Iss 6, Pp e16704- (2023)

مصطلحات موضوعية: Abrocitinib, Upadacitinib, Dupilumab, Moderate-to-severe atopic dermatitis, Randomized controlled trials, Meta-analysis, Science (General), Q1-390, Social sciences (General), H1-99

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844023039117; https://doaj.org/toc/2405-8440

URL الوصول: https://doaj.org/article/b43ac513fc724a05a5ea5429e65bf6c3

المؤلفون: Emma D Deeks (4985300), Sean Duggan (4873369)

مصطلحات موضوعية: Medicine, JAK1 inhibitor, Abrocitinib, Janus kinase 1 inhibitor, moderate-to-severe atopic dermatitis, Adis Drug Review, Adis Insight Report, First approval

Relation: https://figshare.com/articles/online_resource/Abrocitinib_First_Approval/16900546

الاتاحة: https://doi.org/10.6084/m9.figshare.16900546.v1

المؤلفون: Thaçi, Diamant, L. Simpson, Eric, Deleuran, Mette, Kataoka, Yoko, Chen, Zhen, Gadkari, Abhijit, Eckert, Laurent, Akinlade, Bolanle, Graham, Neil M.H., Pirozzi, Gianluca, Ardeleanu, Marius

المصدر: Thaçi , D , L. Simpson , E , Deleuran , M , Kataoka , Y , Chen , Z , Gadkari , A , Eckert , L , Akinlade , B , Graham , N M H , Pirozzi , G & Ardeleanu , M 2019 , ' Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis : a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2) ' , Journal of Dermatological Science , vol. 94 , no. 2 , pp. 266-275 . https://doi.org/10.1016/j.jdermsci.2019.02.002

مصطلحات موضوعية: Adults, Dupilumab, Efficacy, Moderate-to-severe atopic dermatitis, Pooled analysis, Safety

وصف الملف: application/pdf

الاتاحة: https://pure.au.dk/portal/en/publications/099fb0d4-fed3-4d8a-9f5f-dfd41a939bd6
https://doi.org/10.1016/j.jdermsci.2019.02.002
https://pure.au.dk/ws/files/198040552/1_s2.0_S0923181119300283_main.pdf
https://pure.au.dk/ws/files/198040630/1_s2.0_S0923181119300283_main.pdf
http://www.scopus.com/inward/record.url?scp=85065766674&partnerID=8YFLogxK

المؤلفون: Jonathan I. Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E. Pink, Andrea Chiricozzi, Sebastien Barbarot, Thomas Mark, Ann-Marie Tindberg, Stephan Weidinger

المساهمون: Artificial Intelligence supported Modelling in clinical Sciences, Gerontology, Skin function and permeability, Dermatology

المصدر: American journal of clinical dermatology. 23(4)

مصطلحات موضوعية: Adult, Eczema, Dermatitis, Dermatology, interleukin-13, Antibodies, Monoclonal, Humanized, Severity of Illness Index, EASI-75, Antibodies, Atopic, Dermatitis, Atopic, Double-Blind Method, Monoclonal, Humans, Humanized, Glucocorticoids, IGA, phase III ECZTRA 3 trial, Antibodies, Monoclonal, General Medicine, topical corticosteroids, Immunoglobulin A, Treatment Outcome, Quality of Life, Tralokinumab, Dermatologic Agents, Moderate-to-Severe Atopic Dermatitis, Settore MED/35 - MALATTIE CUTANEE E VENEREE

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12337bc7c464140498adda698996f7a8
https://pubmed.ncbi.nlm.nih.gov/35857179

المؤلفون: Gisondi, P., Girolomoni, G.

مصطلحات موضوعية: Undertreatment, moderate-to-severe atopic dermatitis, psoriasis, chronic inflammatory skin diseases, Undertreatment, moderate-to-severe atopic dermatitis, chronic inflammatory skin diseases, psoriasis, chronic urticaria, chronic urticaria

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1943::06bca73ae254c047515f37b33ab7abf4
http://hdl.handle.net/11562/1025924

المؤلفون: P. Gisondi, G. Girolomoni

المساهمون: Gisondi, P., Girolomoni, G.

مصطلحات موضوعية: Undertreatment, moderate-to-severe atopic dermatitis, chronic inflammatory skin diseases, psoriasis, chronic urticaria

وصف الملف: STAMPA

Relation: volume:34; firstpage:2168; lastpage:2169; numberofpages:2; journal:JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY; http://hdl.handle.net/11562/1025924

الاتاحة: http://hdl.handle.net/11562/1025924

المؤلفون: Melinda Gooderham, Panteha Eshtiaghi

المصدر: Core Evidence

مصطلحات موضوعية: medicine.medical_specialty, Review, interleukin-13, Placebo, systemic therapy, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Quality of life, dupilumab, Medicine, biologics, 030212 general & internal medicine, Adverse effect, Pharmacology, business.industry, General Medicine, Atopic dermatitis, medicine.disease, Dupilumab, Dermatology, Clinical trial, Concomitant, Reviews and References (medical), moderate-to-severe atopic dermatitis, Headaches, medicine.symptom, interleukin-4, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d674c5f6d4cb4c65d65907bbff44973
http://europepmc.org/articles/PMC5826246

المؤلفون: Зырянов С.К., Дьяков И.Н., Ильина Н.И.

المصدر: Качественная клиническая практика

مصطلحات موضوعية: moderate to severe atopic dermatitis, therapy, EASI-75, EASI-90, JAK inhibitors, immunobiological drugs, Therapeutic monoclonal antibodies, upadacitinib, baricitinib, dupilumab, атопический дерматит, терапия, ингибиторы JAK, иммунобиологические препараты, терапевтические моноклональные антитела, упадацитиниб, барицитиниб, дупилумаб

Relation: https://repository.rudn.ru/records/article/record/105140/

الاتاحة: https://repository.rudn.ru/records/article/record/105140/